The IAP Antagonist Debio 1143 Enhances Chemoradiotherapy in HNSCC.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2020-116
Abstract: Debio 1143 plus chemoradiotherapy improved head and neck squamous cell carcinoma disease control. read more here.
Keywords: antagonist debio; 1143 enhances; debio; chemoradiotherapy ... See more keywords